临床RNA疗法的进展:当前的发展和未来的前景
1Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China; Nanhai Clinical Translational Center, Sun Yat-sen Memorial Hospital, Foshan 528200, China.
Cell reports. Medicine
|May 14, 2024
概括
RNA疗法为疾病提供了精确的治疗方法,但面临着传递挑战. 本综述涵盖了RNA开发,设计工具和当前的临床应用,包括RNA疫苗.
科学领域:
- 生物技术是生物技术.
- 分子医学是分子医学.
- 药物发现 药物发现 药物发现
背景情况:
- RNA分子显示出作为临床治疗药物的潜力,以高特异性和很少副作用准以前无法治疗的目标.
- 在RNA疗法的关键挑战包括快速降解,细胞膜透性差,和低效的细胞内传递.
- 基于RNA的治疗方法在各种疾病中越来越受欢迎,因此需要全面了解它们的开发和应用.
研究的目的:
- 审查RNA在疾病中的作用,并提供对RNA疗法的演变的历史视角.
- 总结RNA查设计的进展,包括数据库和平台.
- 提供FDA批准的RNA疗法和正在进行的临床试验的最新信息,重点关注RNA药物和疫苗.
主要方法:
- 文献综述和对RNA治疗现有研究的综合.
- 分析RNA查和设计方面的技术发展.
- 关于当前FDA批准的RNA疗法和临床试验进展的数据汇编.
主要成果:
- RNA疗法为针对复杂疾病提供了可行的策略.
- 在克服RNA分子的传递和稳定性挑战方面取得了重大进展.
- 许多基于RNA的药物正在临床试验中,特别关注RNA疫苗和个性化RNA药物.
结论:
- RNA疗法是一个快速发展的领域,有可能彻底改变医学.
- 在输送系统和设计平台的持续创新对于实现RNA疗法的全部潜力至关重要.
- RNA疫苗和RNA药物的开发意味着治疗干预的新时代.
相关概念视频
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
Ribosome Profiling
3.5K
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
3.5K
Types of RNA
5.8K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.8K
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K


